RA Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

RA Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-81,239	Closed	-$252K	–	44
2016 Q1	$252K	Sell	81,239 -559,997	-87%	-$1.88M	0.03%	41
2015 Q4	$2.93M	Buy	+641,236	New	+$3.04M	0.29%	35
2014 Q2	–	Sell	-1,339,039	Closed	-$17M	–	40
2014 Q1	$17M	Sell	1,339,039 -655,837	-33%	-$8.48M	1.22%	22
2013 Q4	$21.6M	Hold	1,994,876	–	–	2.51%	15
2013 Q3	$24.7M	Hold	1,994,876	–	–	2.58%	14
2013 Q2	$26.6M	Buy	+1,994,876	New	+$25.6M	3.53%	11

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

RA Capital Management's DSCI Position: Q2 2016 in Review

RA Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2016, closing a stake of 81,239 shares — an estimated $252K sold.

RA Capital Management first reported a position in DSCI in Q2 2013 and held it in 6 quarters. The position peaked at $26.6M in Q2 2013. 53 funds tracked by Wall St. Rank hold DSCI as of Q2 2016.

RA Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2016 after selling out during the quarter.
RA Capital Management sold 81,239 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2016, an estimated $252K.
RA Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 6 quarters.
RA Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $26.6M in Q2 2013.
53 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2016.

Based on RA Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.